Bravo pour ton gain de 50% 
PP oversubscribed de 600K$
Vancouver, B.C., August 31, 2017 / TheNewswire / UMBRAL ENERGY CORP. (CSE: UMB) (the “ Company ” or “ Umbral ”) is pleased to announce that it has closed its previously announced (see press releases dated July 14, 2017 and August 24, 2017) non-brokered private of 43,700,000 units (the “Units”) at a price of $0.06 per Unit for gross proceeds of $2,622,000 (the “ Offering ”).
Each Unit consists of one common share in the capital of the Company (a “ Share ”) and one common share purchase warrant (a “ Warrant ”). Each Warrant will entitle the holder to purchase one additional Share until August 30, 2019 (subject to acceleration in certain circumstances) at a purchase price of $0.10 per Share.
In connection with the Offering, the Company has paid a cash commission in the aggregate amount of $91,900, being 8% of the aggregate proceeds raised from the sale of units to purchasers introduced by eligible finders. In addition, the Company has issued warrants (the “ Finders’ Warrants ”) to acquire a total of 1,531,653 Shares, being 8% of the number of Units sold under the Offering to purchasers introduced by such finders. Each Finders’ Warrant entitles the holder to purchase one Share at a price of $0.10 per Share until August 30, 2019 (subject to acceleration in certain circumstances).
Clint Sharples, Chairman of Umbral commented, “ I am very proud of the efforts by Jag Bal and his team on this financing. The market is showing tremendous support and confidence in both Umbral and PhyeinMed as evidenced by this raise being significantly oversubscribed. We look forward to continuing to achieve the milestones in our plan over the coming months as we move closer to obtaining our goal of an ACMPR license"
All securities issued in connection with the Offering are subject to a statutory hold period expiring December 31, 2017 in accordance with applicable securities legislation. The proceeds from the Offering will be used to pay the balance of the purchase price for a Falkland, BC property (see press release dated July 13, 2017), completion of phase 1 of the build-out prior to an award of a license to cultivate, fund a work program on the Letourneau Property and for general working capital.
About Umbral Energy Corp.
The Company is currently listed as a junior resource issuer having mineral exploration projects. The Company is considering other activities to increase shareholder value, including non-resource projects. The Company has a mineral exploration project in Quebec. In addition the Company has an interest in PhyeinMed, who has applied for a license from Health Canada to legally grow and sell medical marijuana.
ON BEHALF OF THE BOARD OF DIRECTORS OF UMBRAL ENERGY CORP.
“Jag Bal”
Jagdip Bal
President and CEO
The Canadian Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.
Grosse News ce matin:
Umbral completes early close on Falkland property
2017-09-05 11:01 ET - News Release
Mr. Jagdip Bal reports
UMBRAL COMPLETES EARLY CLOSE ON FALKLAND FACILITY
Umbral Energy Corp. has completed the final payment one month early on the purchase of the Falkland, B.C., property as previously announced on May 10, 2017. The final payment of $895,000 plus closing costs was completed August 31, 2017, and the company now has full access to the property.
The Falkland facility will be used by Umbral’s 75% owned subsidiary PhyeinMed Inc. (“PhyeinMed”), a late stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations). The entire facility consists of 13 acres of land, and includes 10,500 square feet of potential grow area, plus areas identified for a sizeable vault, laboratory, drying room, nursery and office area for a total of 15,500 square feet of facility. Engineering and architectural plans and drawings are already underway, and the company will update shareholders as the b uild-out progresses.
Clint Sharples, Chairman of Umbral states “The closing of the property transaction one month early is a testament to the hard work and efforts by Jag Bal and Debra Senger, and their respective teams at Umbral and PhyeinMed. I am proud of our combined group’s ability to follow through on commitments, and I look forward to watching the continued progression toward our ultimate goal of achieving an ACMPR license from Health Canada.”
PhyeinMed has contracted and has been working with a General Contractor, Architect and Engineering firms to oversee the construction of the project for the past few months. First review of blueprints to tender the project for construction quotes are expected early this week.
Recent rule changes by Health Canada has led to new and creative ways to maximize revenues per square foot, and the professionals that PhyeinMed is working with have previous experience with building pharmaceutical, hospital and ACMPR licensed producer facilities.
“Choosing the right partners was an extremely important process for us.” commented Debra Senger, CEO of PhyeinMed “We are very comfortable with the experience of the companies and the people we have contracted to work with on this project, and we are all focused on completing our build-out on time, and on budget.”
La montée se poursuit tranquillement pas vite. Fermeture à 0.13$ Vendredi
Une entreprise qui fait drolement bien dernierement, cest cannabis wheaton income (cwb.v)… bIls ont annonce une plateforme de licence et ca grimpe depuis!
Edit au 19 septembre: bon ok, cest moins reluisant aujourdhui, jaurais du attendre avant den parler! ce titre est tres volatile…
Un commentaire: 
chuck est quand même le co-fondateur de $WEED Canopy Growth, à suivre !
mettons que IKN n’est pas la meilleure source d’info, pour ne pas dire la pire
En lien avec l’ouverture des législateurs de permettre la légalisation des aliments au thc et du haschich, quels seraient les entreprises qui pourraient en tirer profit? Croyez vous que les producteurs de cannabis vont se doter à l’interne de lignes de produits comestibles ou si des compagnies alimentaires existantes feront le saut en faisant des partenariats? ESt-ce que des entreprises oeuvres déjà dans le domaine de la bouffe potée?
plusieurs producteurs n’attendent juste cela, la légalisation des comestibles.
$UMB est en breakout, la resistance à 0.14$ qui était présente depuis quelques semaines vient d’être brisée
Javoue que je trouve etrange de voir une compagnue miniere avoir une “division” de pot medical… As tu une idee du pourcentage devaluation liee aux activites de marijuana medicale vs les activites minieres? Des activites minieres mal ficelees ou des resultats dexploration décevants ne risquent ils pas de neutraliser
le upside de Phyeinmed?
Merci de ton avis!
L’évaluation est principalent basée sur le projet de marijuana médicale, à 95% je dirais. Il reste un projet minier qui est le Letourneur dans l’Or au Quebec. Ils le garde en vie pour ne pas avoir à passer à travers le changement de listing qui ferait halter le stock un certain temps
On vient d’atteindre un nouveau haut 52sem ainsi qu’un nouveau haut de 5 ans ! Techniquement, le titre est extrêmement bullish, reste plus qu’a laisser les news défiler et Santé Canada faire son travail !